The University of Missouri (Mizzou) in the US has reached a major milestone in ...

An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft ...

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at ...

Ovarian cancer is dangerous and difficult to treat, partly because it’s hard to diagnose early, and partly because it’s often resistant to existing drugs. Now scientists looking for new treatments ...

A cohort study of liver transplant candidates with HCC suggested that local-regional therapy with yttrium-90 transarterial ...

Highlights REAL’ aims to spark vital conversations about advanced prostate cancer and educate about the importance of treatment management WHIPPANY, N.J., January 29, 2026--(BUSINESS WIRE)--Today ...

Approximately 25% of patients with colorectal cancer present with metastatic disease to the liver at diagnosis, and about 50% develop liver metastases at some point during the course of the disease.

Louisville, Ky.-based UofL Health has become the first health system in the state to treat a patient using histotripsy, a noninvasive ultrasound-based therapy for liver tumors. The procedure uses the ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. This work is licensed under a Creative Commons Attribution 4.0 International ...

Background: Ershiyiwei Lvronghao Concentrated Pills (ESYWLRHW) is the concentrated pill developed and prepared based on the classical prescription in Xizang: Ershiwuwei Lvronghao Pills (ESWWLRHW).

Breaking from a one-size-fits-all approach to cancer treatments, a new study from researchers at the UC San Diego School of Medicine in La Jolla indicates a one-size-fits-one model may be even more ...